Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CRNX |
---|---|---|
09:32 ET | 16945 | 51.765 |
09:34 ET | 650 | 51.36 |
09:36 ET | 1790 | 51.33 |
09:38 ET | 100 | 51.335 |
09:39 ET | 1319 | 51.37 |
09:41 ET | 1130 | 51.39 |
09:43 ET | 1895 | 51.46 |
09:48 ET | 2581 | 51.39 |
09:54 ET | 435 | 51.47 |
09:56 ET | 100 | 51.395 |
09:57 ET | 200 | 51.39 |
09:59 ET | 2700 | 51.355 |
10:01 ET | 1100 | 51.315 |
10:03 ET | 600 | 51.34 |
10:06 ET | 600 | 51.34 |
10:08 ET | 1111 | 51.0201 |
10:10 ET | 1000 | 51.07 |
10:12 ET | 489 | 50.96 |
10:14 ET | 1700 | 50.5 |
10:15 ET | 2128 | 50.78 |
10:17 ET | 900 | 50.79 |
10:19 ET | 802 | 50.94 |
10:21 ET | 100 | 50.945 |
10:26 ET | 600 | 50.735 |
10:28 ET | 1800 | 50.76 |
10:30 ET | 300 | 50.79 |
10:32 ET | 967 | 50.765 |
10:33 ET | 977 | 50.875 |
10:35 ET | 100 | 50.9 |
10:37 ET | 2600 | 50.83 |
10:39 ET | 100 | 50.825 |
10:42 ET | 550 | 50.885 |
10:44 ET | 1000 | 51.04 |
10:46 ET | 7979 | 50.99 |
10:48 ET | 400 | 51.04 |
10:50 ET | 7700 | 51.02 |
10:53 ET | 2400 | 51.08 |
10:55 ET | 500 | 51.015 |
10:57 ET | 1100 | 51 |
11:00 ET | 1100 | 51.01 |
11:02 ET | 1579 | 50.99 |
11:04 ET | 4070 | 50.965 |
11:06 ET | 800 | 50.98 |
11:08 ET | 700 | 51 |
11:11 ET | 400 | 50.97 |
11:13 ET | 400 | 51.07 |
11:15 ET | 1150 | 51.11 |
11:18 ET | 100 | 51.13 |
11:22 ET | 200 | 51.17 |
11:24 ET | 2808 | 51.19 |
11:26 ET | 11300 | 51.33 |
11:27 ET | 200 | 51.345 |
11:29 ET | 200 | 51.34 |
11:31 ET | 2530 | 51.3 |
11:33 ET | 1200 | 51.1 |
11:36 ET | 1537 | 51.23 |
11:38 ET | 900 | 51.18 |
11:40 ET | 300 | 51.24 |
11:42 ET | 1400 | 51.145 |
11:44 ET | 100 | 51.14 |
11:45 ET | 2619 | 51.155 |
11:47 ET | 1969 | 51.1 |
11:49 ET | 100 | 51.08 |
11:51 ET | 1500 | 51.13 |
11:54 ET | 400 | 51.17 |
11:58 ET | 600 | 51.15 |
12:00 ET | 500 | 51.19 |
12:02 ET | 100 | 51.2 |
12:05 ET | 2644 | 51.155 |
12:07 ET | 300 | 51.215 |
12:09 ET | 500 | 51.15 |
12:12 ET | 300 | 51.23 |
12:14 ET | 48300 | 51.45 |
12:16 ET | 20941 | 51.43 |
12:18 ET | 1400 | 51.62 |
12:20 ET | 300 | 51.68 |
12:21 ET | 621 | 51.56 |
12:25 ET | 100 | 51.555 |
12:27 ET | 618 | 51.55 |
12:30 ET | 300 | 51.56 |
12:32 ET | 300 | 51.59 |
12:34 ET | 200 | 51.53 |
12:36 ET | 1022 | 51.49 |
12:38 ET | 500 | 51.63 |
12:39 ET | 400 | 51.645 |
12:41 ET | 100 | 51.63 |
12:43 ET | 1726 | 51.77 |
12:45 ET | 1000 | 51.805 |
12:48 ET | 458 | 51.78 |
12:50 ET | 1753 | 51.79 |
12:52 ET | 300 | 51.795 |
12:54 ET | 100 | 51.775 |
12:56 ET | 400 | 51.81 |
12:57 ET | 200 | 51.81 |
12:59 ET | 702 | 51.87 |
01:01 ET | 663 | 51.81 |
01:03 ET | 400 | 51.825 |
01:06 ET | 100 | 51.81 |
01:08 ET | 200 | 51.805 |
01:10 ET | 600 | 51.85 |
01:12 ET | 1008 | 51.81 |
01:14 ET | 100 | 51.76 |
01:15 ET | 1738 | 51.73 |
01:17 ET | 1208 | 51.79 |
01:19 ET | 200 | 51.74 |
01:21 ET | 1400 | 51.765 |
01:24 ET | 400 | 51.785 |
01:26 ET | 100 | 51.775 |
01:28 ET | 1300 | 51.735 |
01:30 ET | 200 | 51.74 |
01:32 ET | 1900 | 51.79 |
01:33 ET | 500 | 51.795 |
01:35 ET | 700 | 51.695 |
01:37 ET | 300 | 51.67 |
01:39 ET | 200 | 51.6675 |
01:42 ET | 400 | 51.605 |
01:44 ET | 497 | 51.59 |
01:46 ET | 253 | 51.55 |
01:48 ET | 600 | 51.6 |
01:50 ET | 800 | 51.63 |
01:51 ET | 1107 | 51.67 |
01:53 ET | 300 | 51.6225 |
01:55 ET | 200 | 51.6 |
01:57 ET | 2000 | 51.72 |
02:00 ET | 200 | 51.73 |
02:02 ET | 505 | 51.73 |
02:04 ET | 2836 | 51.605 |
02:06 ET | 100 | 51.605 |
02:08 ET | 600 | 51.6 |
02:09 ET | 300 | 51.6 |
02:11 ET | 300 | 51.56 |
02:13 ET | 700 | 51.54 |
02:15 ET | 400 | 51.53 |
02:18 ET | 400 | 51.535 |
02:20 ET | 692 | 51.32 |
02:22 ET | 200 | 51.31 |
02:24 ET | 1193 | 51.26 |
02:26 ET | 1782 | 51.27 |
02:27 ET | 300 | 51.28 |
02:29 ET | 1618 | 51.36 |
02:31 ET | 900 | 51.46 |
02:33 ET | 200 | 51.46 |
02:36 ET | 100 | 51.375 |
02:38 ET | 1000 | 51.345 |
02:40 ET | 1300 | 51.44 |
02:42 ET | 300 | 51.48 |
02:44 ET | 800 | 51.42 |
02:45 ET | 100 | 51.39 |
02:47 ET | 200 | 51.365 |
02:49 ET | 900 | 51.35 |
02:51 ET | 800 | 51.33 |
02:54 ET | 1500 | 51.43 |
02:56 ET | 300 | 51.44 |
02:58 ET | 100 | 51.41 |
03:00 ET | 100 | 51.425 |
03:02 ET | 1600 | 51.4 |
03:03 ET | 1200 | 51.38 |
03:05 ET | 1108 | 51.44 |
03:09 ET | 1040 | 51.4 |
03:12 ET | 1008 | 51.43 |
03:14 ET | 400 | 51.455 |
03:16 ET | 1900 | 51.495 |
03:18 ET | 3100 | 51.6 |
03:20 ET | 2100 | 51.47 |
03:21 ET | 27989 | 51.51 |
03:23 ET | 1200 | 51.5 |
03:25 ET | 3400 | 51.585 |
03:27 ET | 900 | 51.465 |
03:30 ET | 800 | 51.52 |
03:32 ET | 1400 | 51.52 |
03:34 ET | 2800 | 51.29 |
03:36 ET | 1600 | 51.275 |
03:38 ET | 908 | 51.285 |
03:39 ET | 1100 | 51.265 |
03:41 ET | 3129 | 51.3 |
03:43 ET | 500 | 51.3 |
03:45 ET | 1700 | 51.295 |
03:48 ET | 1608 | 51.28 |
03:50 ET | 4477 | 51.25 |
03:52 ET | 4224 | 51.33 |
03:54 ET | 3025 | 51.515 |
03:56 ET | 8417 | 51.52 |
03:57 ET | 8917 | 51.47 |
03:59 ET | 21544 | 51.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.1B | -13.6x | --- |
Immunovant Inc | 4.6B | -16.8x | --- |
Madrigal Pharmaceuticals Inc | 4.6B | -9.5x | --- |
Nuvalent Inc | 4.7B | -29.4x | --- |
Alpine Immune Sciences Inc | 4.5B | -95.0x | --- |
Biohaven Ltd | 3.4B | -5.5x | --- |
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.1B |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.69 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -13.6x |
Price/Sales (TTM) | 2,073.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.